CA2020199A1 - Uses of sulphated sugars - Google Patents
Uses of sulphated sugarsInfo
- Publication number
- CA2020199A1 CA2020199A1 CA 2020199 CA2020199A CA2020199A1 CA 2020199 A1 CA2020199 A1 CA 2020199A1 CA 2020199 CA2020199 CA 2020199 CA 2020199 A CA2020199 A CA 2020199A CA 2020199 A1 CA2020199 A1 CA 2020199A1
- Authority
- CA
- Canada
- Prior art keywords
- skin
- treatment
- prophylaxis
- medicament
- connective tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000000346 sugar Nutrition 0.000 title 1
- 150000008163 sugars Chemical class 0.000 title 1
- 238000011282 treatment Methods 0.000 abstract 5
- 238000011321 prophylaxis Methods 0.000 abstract 4
- 210000002808 connective tissue Anatomy 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 210000002200 mouth mucosa Anatomy 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 230000002496 gastric effect Effects 0.000 abstract 2
- 230000003211 malignant effect Effects 0.000 abstract 2
- 239000002674 ointment Substances 0.000 abstract 2
- 230000000699 topical effect Effects 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000034693 Laceration Diseases 0.000 abstract 1
- 208000002847 Surgical Wound Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 150000002016 disaccharides Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 230000008105 immune reaction Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 150000002772 monosaccharides Chemical class 0.000 abstract 1
- 239000006072 paste Substances 0.000 abstract 1
- 239000011505 plaster Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000008439 repair process Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000036269 ulceration Effects 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Use of a sulphated mono- or disaccharide or a salt or complex thereof for the preparation of a medicament for topical application to the skin or to any non-gastrointestinal, non-oral mucosal surface of an animal or a human, including the lining of body cavities, for the prophylaxis or treatment of any manifestation of inflammation or infection, for modification or facilitation of tissue regenerative processes, for the modulation of immune reactions, for the treatment or prophylaxis of non-bladder pre-malignant or malignant disorders, or for the prophylaxis or treatment of irritation, burns, or ulcera-tion of the skin, connective tissue, or non-gastrointestinal, non-oral mucosa; or for the preparation of a medicament for topical application to the skin or any non-oral mucosal surface of an animal or a human for the treatment of laceration, lesions, or surgical wounds of the skin, connective tissue, or non-oral mucosa, or for the prophylaxis or treatment of aging of skin, connective tissue, or non-oral mucosa. The medicament may be in the form of a powder, paste, ointment, lotion, gel, cream, salve, emulsion, suspension, solution, spray, sponge, strip, plaster, pad, dressing, or ostomy plate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2020199 CA2020199C (en) | 1990-06-29 | 1990-06-29 | Uses of sulphated sugars |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2020199 CA2020199C (en) | 1990-06-29 | 1990-06-29 | Uses of sulphated sugars |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2020199A1 true CA2020199A1 (en) | 1991-12-30 |
| CA2020199C CA2020199C (en) | 2002-08-20 |
Family
ID=4145381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2020199 Expired - Fee Related CA2020199C (en) | 1990-06-29 | 1990-06-29 | Uses of sulphated sugars |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2020199C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083933A (en) * | 1999-04-19 | 2000-07-04 | Stellar International Inc. | Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution |
| US7772210B2 (en) | 2003-02-19 | 2010-08-10 | Stellar Pharmaceuticals Inc. | Cystitis treatment with high dose chondroitin sulfate |
| WO2020076501A1 (en) * | 2018-10-10 | 2020-04-16 | Hollister Incorporated | Stoma powder including skin health ingredients |
| US11291684B2 (en) | 2017-05-17 | 2022-04-05 | Tx Medic Ab | Treatment of glaucoma |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2908911A1 (en) * | 2012-10-17 | 2015-08-26 | Interalia S.r.l. | Compositions comprising a silver salt of sucrose octasulfate and a potassium salt of sucrose octasulfate for protection of mucosal epithelia |
-
1990
- 1990-06-29 CA CA 2020199 patent/CA2020199C/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083933A (en) * | 1999-04-19 | 2000-07-04 | Stellar International Inc. | Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution |
| US7772210B2 (en) | 2003-02-19 | 2010-08-10 | Stellar Pharmaceuticals Inc. | Cystitis treatment with high dose chondroitin sulfate |
| US8084441B2 (en) | 2003-02-19 | 2011-12-27 | Stellar Pharmaceuticals, Inc. | Cystitis treatment with high dose chondroitin sulfate |
| US8334276B2 (en) | 2003-02-19 | 2012-12-18 | Stellar Pharmaceuticals Inc. | Cystitis treatment with high dose chondroitin sulfate |
| US8778908B2 (en) | 2003-02-19 | 2014-07-15 | Stellar International Inc. | Cystitis treatment with high dose chondroitin sulfate |
| US11291684B2 (en) | 2017-05-17 | 2022-04-05 | Tx Medic Ab | Treatment of glaucoma |
| WO2020076501A1 (en) * | 2018-10-10 | 2020-04-16 | Hollister Incorporated | Stoma powder including skin health ingredients |
| CN113038935A (en) * | 2018-10-10 | 2021-06-25 | 霍利斯特公司 | Ostomy powder containing skin healing ingredients |
| AU2019356464B2 (en) * | 2018-10-10 | 2024-08-22 | Hollister Incorporated | Stoma powder including skin health ingredients |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2020199C (en) | 2002-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK151590A (en) | USE OF SULPHATED SUGAR | |
| ATE363283T1 (en) | TERFENADINE CARBOXYLATE AND THE TREATMENT OF SKIN IRRITATION | |
| CA2000548A1 (en) | Conformable bandage and coating material | |
| IL43167A (en) | Phosphine oxides having a physiological cooling effect and compositions containing them | |
| CA2452151A1 (en) | Use of cyclopamine, an inducer of the differentiation and apoptosis of the basal cell carcinoma (bcc) cells, in the treatment of bcc's and other tumors that use the hedgehog/smoothened pathway for proliferation of apoptosis | |
| PL330768A1 (en) | Perpetration for use in therapy and prophylactics of dermatological diseases | |
| EP0219455A3 (en) | Pharmaceutical and cosmetic compositions containing n-acetylcysteine | |
| WO2004100923A1 (en) | The composition for external use by percutaneous administration | |
| CA2020199A1 (en) | Uses of sulphated sugars | |
| JPH0522689B2 (en) | ||
| IT1230157B (en) | USE OF WET SUCRALPHATE FOR THE TREATMENT OF DERMA ULCERS AND AS A VEHICLE OF DRUGS WITH TOPICAL ACTIVITY | |
| CN105169457B (en) | A kind of cation medical dressing and preparation method thereof | |
| EP0242553A1 (en) | Use of allantoin and sulfur in the manufacture of a medicament for the treatment of odontostomatologic diseases | |
| JP2004534076A (en) | Use of glycoproteins for wound healing and reepithelialization | |
| JPH039885B2 (en) | ||
| CN105056288B (en) | Medical hemorrhoid biological hydrogel functional dressings and preparation method thereof | |
| FR2757391B1 (en) | USE OF AN EXTRACT FROM THE TERMINALIA PLANT, IN THE COSMETIC AND PHARMACEUTICAL AREAS, ESPECIALLY DERMATOLOGICAL | |
| CN105616296A (en) | Populus tomentosa itch-stopping skin-protecting paste | |
| US20050191354A1 (en) | Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent | |
| CA2126704C (en) | Dermatological compositions and methods for the treatment of skin therewith | |
| KR20040087006A (en) | Seat-type hydrogel pack using water soluble polymer and the manufacturing process thereof | |
| El‐Hefnawi et al. | Studies on Pityriasis Versicolor in Egypt: II. Clinical and Therapeutic | |
| SU1475669A1 (en) | Agent for prevention and treatment of frostbites | |
| CA2097878A1 (en) | Therapeutic agent for neutropenia | |
| WO2000024370A1 (en) | Dermatologic gels for the treatment of acne vulgaris and herpes simplex containing methenamine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |